Ardian strengthens its commitment to Dedalus, driving the next phase of growth with a new investment and the appointment of a new Group CEO

Ardian

Ardian agreed to increase its stake in Dedalus to 92%, with founder Giorgio Moretti retaining a 6% stake in the Company and remaining board member.
• Alberto Calcagno appointed Group CEO and Andrea Fiumicelli made Chairman.

A consortium led by Ardian, a world leading private investment house, has agreed to acquire an additional 19% stake in Dedalus, a leading European player in the healthcare software industry, from founder Giorgio Moretti. Subject to customary authorizations by the competent authorities, upon completion of the transaction, the consortium led by Ardian will indirectly hold a 92% stake in the Company, with Moretti retaining a 6% stake and a seat in the board.

The agreement aims to support Dedalus through a new phase of expansion.

As part of this growth plan, Alberto Calcagno, former CEO of Italian ICT company Fastweb, which has seen significant constant growth over the past 10 years, has been appointed as new CEO, effective from October 18.

Andrea Fiumicelli, who has managed Dedalus over the last few years and contributed significantly to the company’s further development through several strategic M&A deals, has been appointed Chairman.

“Ardian is fully committed to supporting Dedalus throughout its next period of growth, in which it aims to serve its clients and deliver its mission of improving healthcare for over 500 million patients globally. Ardian and I want to thank Giorgio Moretti for his vision and execution since our initial investment”. Marco Bellino, Managing Director Buyout, Ardian

“After a long journey that began in Florence 40 years ago, the time has come for Dedalus to expand. This agreement will help the company to further invest in innovation, in line with our mission. Alberto Calcagno will bring strong skills and new energy to the Group’s operations and future strategic development. I will remain a shareholder in Dedalus, together with my longtime partner Three Hills, fully supporting the new CEO and the company’s project”. Giorgio Moretti, Founder, Dedalus

“I am very happy to join Dedalus to drive its ambitious growth plans. Today, the healthcare software industry is privileged to have the responsibility of leading on critical digital transformation to improve the well-being of millions of patients. Dedalus’ mission is to accelerate and deliver this change as soon as possible”. Alberto Calcagno, new CEO, Dedalus

“In the last four years we have successfully re-designed our software portfolio and established sales and delivery operations in 25 countries. This new governance structure strengthens our commitment to our mission and future clients. We aim to deliver faster innovation and high-quality services, be the best employer in the sector and serve our shareholders’ ambitions”. Andrea Fiumicelli, new Chairman, Dedalus

Ardian has invested in Dedalus in several stages since 2016, supporting a strong M&A strategy which has seen the Company become a pan-European leader in its sector.

ABOUT DEDALUS

Founded in 1982 in Florence by Giorgio Moretti, Dedalus Group is the leading healthcare and diagnostic software provider in Europe, supporting globally the digital transformation of 6700 Healthcare Organisations and 5700 Labs and Diagnostic centres worldwide, processing its solutions for more than 540 millions of population worldwide. Dedalus offer supports the whole continuum of care, offering open standards-based solutions serving each actor of the Healthcare Ecosystem to provide better care in a healthier planet. Life Flows through our software.

ABOUT ARDIAN

Ardian is a world-leading private investment house, managing or advising $156bn of assets on behalf of more than 1,470 clients globally. Our broad expertise, spanning Private Equity, Real Assets and Credit, enables us to offer a wide range of investment opportunities and respond flexibly to our clients’ differing needs. Through Ardian Customized Solutions we create bespoke portfolios that allow institutional clients to specify the precise mix of assets they require and to gain access to funds managed by leading third-party sponsors. Private Wealth Solutions offers dedicated services and access solutions for private banks, family offices and private institutional investors worldwide. Ardian’s main shareholding group is its employees and we place great emphasis on developing its people and fostering a collaborative culture based on collective intelligence. Our 1,050+ employees, spread across 16 offices in Europe, the Americas, Asia and Middle East are strongly committed to the principles of Responsible Investment and are determined to make finance a force for good in society. Our goal is to deliver excellent investment performance combined with high ethical standards and social responsibility.
At Ardian we invest all of ourselves in building companies that last.

PRESS CONTACT

ARDIAN

Categories: News People

Tags:

Ratos Company Semcon spins off its Product Information business area, introduces Aleido

Ratos

Semcon announces the successful spinoff of its Product Information business area, marking the official launch of new and stand-alone company Aleido. This strategic step has been taken to strengthen both businesses and to continue growing their offers, dedicated teams, and profitability.

The Product Information business area, with its 850 employees in five countries, is known for its expertise in creating user-friendly digital aftermarket solutions for complex products. As a global leader, it serves customers such as Volvo Cars, Tetra Pak, Alstom, AGCO, Jaguar Land Rover and Epiroc.

“At Ratos we are strong believers of a decentralised model and are convinced that it drives entrepreneurial spirit, growth and efficiencies. This move ensures that each company can follow its own independent growth journey and realise its true potential,” says Anders Slettengren, Chairman of the Board of Semcon and Aleido and Executive Vice President at Ratos.

Leaders in aftermarket information
Aleido specialises in both aftermarket information and learning solutions. Within aftermarket information, the company can draw on decades of experience and today support customers in five different markets. And thanks to recent acquisitions within learning, Aleido is the largest digital learning company in Scandinavia. Guided by its mission, ‘to make the advanced simply understood’, Aleido provides knowledge that bridges the gap between technology and people.

“This is a significant milestone, and we can proudly announce that the former Semcon business area, Product Information, is now a stand-alone company: Aleido. As we embark on this new journey, we’re eager to embrace the opportunities ahead with even more focus and dedication,” says Johan Ekener, CEO of Aleido.

A strategic technology partner
Semcon has more than 40 years of experience of product, production and service development. Going forward, it will pursue its strong position as an international technology partner for companies and organisations in transformation. With a unique offering combining engineering, digital excellence and sustainability know-how, Semcon’s experts and cross-functional teams makes its customers more competitive and improve the user experience and sustainability of their solutions.

“Every day, our experts add new perspectives that help create solutions that make a difference to people and the planet. With a more focused operation, we are now accelerating our combined offering to provide even greater customer value,” says Markus Granlund, CEO of Semcon.

For more information, please contact:
Josefine Uppling, VP Communication, Ratos, +46 76 114 54 21
Lena Söderholm, Chief Communication Officer, Aleido, +46 706 121 346
Kristina Ekeblad, Head of Communication and Marketing, Semcon,+46 704 130 926

About Ratos
Ratos is a business group consisting of 17 companies divided into three business areas: Construction & Services, Consumer and Industry. The companies have approximately SEK 33 billion in net sales (LTM). Our business concept is to own and develop companies that are or can become market leaders. We have a distinct corporate culture and strategy – everything we do is based on our core values: Simplicity, Speed in execution and It’s All About People. We enable independent companies to excel by being part of something larger. People, leadership, culture and values are key focus areas.

Categories: News

Tags:

KKR To Invest In Life Sciences Firm Catalio Capital Management

KKR

KKR buys minority stake in Catalio and invests in its funds

Investment is additive to KKR’s existing health care growth strategy

NEW YORK–(BUSINESS WIRE)– KKR, a leading global investment firm, today announced an agreement to invest in Catalio Capital Management, LP, a multi-strategy investment firm focused on breakthrough biomedical technology and innovative health care companies. The addition of new capital is expected to accelerate Catalio’s growth trajectory and talent acquisition, as well as anchor its investment strategies. Pursuant to the agreement, KKR is acquiring a minority economic stake in Catalio and will invest in Catalio’s funds.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231017308280/en/

Henry Kravis, Co-Founder and Co-Executive Chairman of KKR, will be named as the Chairman of a new Board of Advisors for Catalio that will help guide the strategic growth of the business. Members of the Catalio Board of Advisors will include, among others, Alex Gorsky, the retired Chairman & CEO of Johnson & Johnson, Andrew Liveris, the retired Chairman & CEO of Dow Chemical Co., Dina Powell McCormick, the Vice Chairman & President of Global Client Services at BDT & MSD, and Tim J. O’Neill, a longtime Partner and retired Co-Head of Goldman Sachs Asset Management.

“The life sciences sector represents a growing market opportunity and has been an important area of focus for our health care growth strategy, which will be further accelerated through our partnership with Catalio. We are impressed not only by Catalio’s entrepreneurial leadership team but also by its vast network of leading scientists who serve as venture partners,” said Ali Satvat, Partner, Co-Head of Americas Health Care and Global Head of Health Care Strategic Growth at KKR. “We look forward to supporting Catalio in taking the platform to the next level and unlocking the next generation of biomedical technology.”

“We are grateful to KKR for its support, which we believe affirms the success of Catalio’s strategy and recognizes the value of our experienced life sciences investment team,” said George Petrocheilos and R. Jacob Vogelstein, Co-Founders and Managing Partners of Catalio. “KKR’s investment comes at an exciting time in Catalio’s development. We believe that we will now be even better positioned to empower the world’s most innovative clinical scientists to turn next-generation biomedical discoveries into valuable treatments and cures and create profitable, well-run companies that advance the boundaries of care.”

Following the completion of the transaction, Mr. Petrocheilos and Dr. Vogelstein will continue to own a controlling stake in Catalio, and the day-to-day management and operation of the Catalio business will remain the same.

KKR has a long track record of supporting health care companies globally, having committed over $20 billion to the sector since 2004. In the life sciences sector specifically, KKR has already committed well over $1 billion in capital from its health care growth strategy, including investments in BridgeBio Pharma, Dawn Bio and Treeline Biosciences, and will be funding this investment from its balance sheet. KKR’s health care growth strategy is focused on investing in high-growth health care-related companies to which KKR can be a unique strategic partner in helping reach scale.

Kirkland & Ellis LLP served as legal advisor to KKR. Paul, Weiss, Rifkind, Wharton & Garrison LLP served as legal advisor to Catalio.

About KKR

KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at www.globalatlantic.com.

About Catalio

Catalio Capital Management, LP, is a multi-strategy life sciences investment firm focusing on breakthrough biomedical technology companies developing the next generation of drugs, devices, diagnostics, and data-driven insights. Catalio has partnered with over 44 world-renowned scientists with extensive academic and scientific achievements who have each also started well-established companies based on their research. Catalio has offices in New York and London. Learn more about Catalio Capital Management by visiting www.cataliocapital.com.

Media:
Liidia Liuksila
212-750-8300
media@kkr.com

Charles V. Zehren
212-843-8590
czehren@rubenstein.com

Source: KKR

Categories: News

Tags:

Gatekeeper Announces Strategic Growth Investment from Vista Equity Partners

Vista Equity

Categories: News

Tags:

KKR and Flerie form specialized pharma services platform Frontier Biosolutions and invest in Coriolis Pharma

KKR
  • KKR and Flerie to support organic and inorganic growth to extend Coriolis’ leadership position in formulation development and analytical services for innovative high-value biologics and cell and gene therapy products
  • Experienced team of biopharma services veterans led by Thomas Eldered of Flerie Invest AB (“Flerie”) to provide strategic advice and operational support to Frontier’s portfolio companies, including Coriolis

MUNICH–(BUSINESS WIRE)– KKR, a leading global investment firm, today announced, in partnership with Flerie, the formation of a new global pharma services platform, Frontier Biosolutions (“Frontier”), which will invest in a portfolio of companies focused on specialized pharmaceutical services to advanced therapeutics customers. Frontier will invest in differentiated scientific capabilities and proprietary technology platforms that address critical bottlenecks in the development and manufacturing of advanced therapeutics.

Industry veteran and co-investor Thomas Eldered will serve as Frontier’s Executive Chairman, bringing more than 34 years of senior management expertise to the management board and drawing on his experience as Co-founder of Recipharm and as a life sciences investor at Flerie. He will be joined by Mark Quick, formerly Head of M&A at Recipharm now Partner at Flerie, Stephan Kutzer, formerly CEO at Alcami and Divisional CEO and COO at Lonza Pharma and Biotech, Danielle Young, formerly Head of Commercial Strategy at Alcami, and Phil Vanek, currently CTO at Gamma Biosciences.

As the platform’s foundational investment, funds managed by KKR and Flerie, through Frontier, have invested in Munich-based Coriolis Pharma, a global leader in formulation research and development, analytical services and non-GMP manufacturing of innovative high-value biologics and cell and gene therapy products. With its scientific expertise, Coriolis enables its clients to create high quality drug products with global commercial potential from early development to product commercialization. KKR’s investment will enable Coriolis’ continued expansion, especially into the fast-growing cell and gene therapy segment and will expand its range of services offered to customers globally.

“We are thrilled to partner with Flerie and Thomas Eldered, the experienced Board of Directors, and the team at Coriolis Pharma at a time of growing demand for specialized services to support the development of advanced therapeutics,” said Kugan Sathiyanandarajah, Managing Director and Head of KKR’s Health Care Strategic Growth business in Europe. “This platform and the investment in Coriolis Pharma are another example of our Health Care Strategic Growth platform strategy to partner with proven operators in an area we have been following for some time.”

“We are very excited to launch Frontier Biosolutions as a global platform that we believe will enable its future portfolio companies to understand and address the evolving needs in drug development,” said Thomas Eldered. “Coriolis Pharma has an industry-leading track record as a global provider of mission-critical, highly specialized formulation development services and a reputation for scientific leadership and complex problem solving. I look forward to working with the outstanding management team at Coriolis as they pursue their ambitious growth plans.”

Michael Wiggenhorn, Co-Founder of Coriolis, commented: “This investment presents a pivotal growth opportunity for Coriolis to realize our strategy and vision. The ability to leverage Frontier’s collective skills and expertise will be invaluable as we revolutionize the development process of biopharmaceutical drugs. Together with a strong suite of industry advisors and KKR’s global network and market knowledge, we will be able to position Coriolis for the future and move one step closer to our goal of making future therapies available to humankind efficiently and on time.”

KKR is investing in Coriolis Pharma through its KKR Health Care Strategic Growth Fund II, a $4.0 billion fund focused on investing in high-growth health care companies. KKR has a long track record of supporting health care companies globally, having invested approximately $19 billion in the sector since 2004.

The investment in Coriolis Pharma underscores KKR’s strong presence in the German-speaking DACH region, where KKR has invested more than €15 billion of long-term equity capital in over 30 companies since 1999. Currently, approximately 40 of KKR’s global portfolio companies operate in the DACH region.

About KKR

KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at www.globalatlantic.com.

About Flerie

Flerie is an active long-term global biotech and pharma investor based in Stockholm and London managing a portfolio of 30 companies in Europe, Israel and the US. Flerie’s evergreen investment strategy, operational expertise and network enables pioneering technologies in the drug development and services space to advance on their path to treating patients and commercialization. Flerie was founded in 2011 by Thomas Eldered, who also co-founded and built Recipharm to be one of the world’s top five pharmaceutical contract manufacturers. For more information, please visit www.flerie.com.

About Coriolis Pharma

Coriolis Pharma is a globally operating contract research and development organization (CRDO) and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs, including cell and gene therapy products and vaccines. It is the vision of Coriolis to revolutionize the development process of biopharmaceutical drugs by integrating innovative digital formulation approaches from drug development to commercial products. With its interdisciplinary team of highly skilled scientists and an expert scientific advisory board, Coriolis provides cutting-edge services and tailor-made solutions for its clients. Coriolis was founded in 2008 and currently employs more than 200 employees from over 36 nations around the world. For more information visit www.coriolis-pharma.com.

KKR media contact

Thea Bichmann
Mobile: +49 (0) 172 13 99 761
Email: kkr_germany@fgsglobal.com

Fabian Prietzel
Mobile: +49 (0) 171 86 01 411
Email: kkr_germany@fgsglobal.com

Coriolis media contact

Bettina von Klitzing-Stückle
Mobile: +49 (0) 151 52 61 38 97
Email: bettina.klitzing@coriolis-pharma.com

Source: KKR

Categories: News

Tags:

LOGISTEC Corporation enters into definitive agreement to be acquired by Blue Wolf Capital Partners

LOGISTEC shareholders to receive $67.00 in cash per share pursuant to the transaction

Blue Wolf to maintain head office in Québec with significant investment for future growth initiatives

Montréal, Québec, October 16, 2023 – LOGISTEC Corporation (TSX: LGT.A LGT.B) (“LOGISTEC” or the “Corporation”) today announced that it has entered into an arrangement agreement (the “Arrangement Agreement”) with 1443373 B.C. Unlimited Liability Company (the “Purchaser”), an entity owned by certain funds managed by Blue Wolf Capital Partners LLC (“Blue Wolf”) in partnership with Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets, pursuant to which the Purchaser will acquire all the issued and outstanding shares of the Corporation for $67.00 in cash per share, representing a total enterprise value of approximately $1.2 billion, subject to customary closing conditions.

The Arrangement Agreement is the culmination of an extensive and robust review of strategic alternatives available to maximize shareholder value that was conducted by a Special Committee of independent directors of the Corporation at the request of its principal shareholder, Sumanic Investments Inc.

The consideration offered under the transaction represents a 61.2% premium to the unaffected 20‑day volume-weighted average trading price per Class A Common Share and a 62.2% premium to the unaffected 20-day volume-weighted average trading price per Class B Subordinate Voting Share on the Toronto Stock Exchange on May 19, 2023, the last trading day prior to the announcement of the strategic review process, and a 14.5% premium to the 20-day volume-weighted average trading price per Class A Common Share and a 9.9% premium to the 20-day volume-weighted average trading price per Class B Subordinate Voting Share on the Toronto Stock Exchange on October 13, 2023.

“Since my father started this business more than 70 years ago, we have grown into industry leaders,” said Madeleine Paquin, President and Chief Executive Officer of LOGISTEC. “As we enter this next phase of our journey, we will continue to build a sustainable future by facilitating trade, handling our customers’ goods safely, and protecting our environment as well as our water resources for the next generation. We see significant opportunity to collaborate with Blue Wolf to drive value creation for our people, our customers, and our communities while rewarding our existing shareholders with an attractive cash consideration providing immediate and fair value for their shares.”

“After a comprehensive and rigorous strategic review process, we are pleased to have agreed terms on a transaction with Blue Wolf that has the full support of LOGISTEC’s Board of Directors and Special Committee,” said J. Mark Rodger, LOGISTEC’s Chairman of the Board of Directors and of its Special Committee. “After careful deliberation, the Special Committee and the Board of Directors have unanimously concluded that the transaction is fair to LOGISTEC’s shareholders and is in the best interests of LOGISTEC and its employees and other stakeholders.”

LOGISTEC will Remain a Quebec Based Business with Significant Blue Wolf Investment

“Blue Wolf is excited to enter the Québec market with this acquisition, which represents excellent prospects for continued growth for both of the Corporation’s business segments and throughout North America,” said Bennet Grill, Principal at Blue Wolf. Natalie Marjancik, Partner at Blue Wolf, added, “We are committed to maintaining LOGISTEC’s core values of quality and innovative services, respect for people and the environment. We look forward to continued growth and working alongside the current management teams in place in Québec and elsewhere.”

Blue Wolf’s business plan is anchored in making significant contributions to the business and to the Québec and Canadian economy, including:

  • Maintaining LOGISTEC’s head office in the Province of Québec;
  • Working with the current management teams to drive continued growth in the operations and employment of the business;
  • Future investment of more than $200 million in capital expenditures and growth initiatives; and
  • Continuing contributions to current charitable and social causes in Québec supported by LOGISTEC.

Other Investment Partners

Blue Wolf is funding its portion of the purchase price with capital it manages on behalf of its limited partners via private equity fund capital as well as select co-investors, together with an additional preferred investment in the Purchaser by Stonepeak.

“The specialized services LOGISTEC provides through its terminal operations to a diversified global customer base make it a quality infrastructure asset,” said James Wyper, Senior Managing Director at Stonepeak. “Between its Marine Services and Environmental Services business, which is focused on rehabilitating aging water infrastructure and remediating soil, we believe in the compelling opportunities for growth and in the future success of LOGISTEC. We are excited to support the Corporation, in partnership with Blue Wolf, in its next chapter.”

“The gouvernement du Québec through Investissement Québec is in discussion with Blue Wolf for a potential investment in the Corporation,” said Guy LeBlanc, President and CEO of Investissement Québec (“IQ“). “IQ’s potential participation in the Corporation will support Blue Wolf’s commitment to maintain LOGISTEC’s headquarters and operations in Québec and to continue to make investments in Québec. We would like to thank and congratulate the Paquin Family for having built a sector champion solidly anchored in Québec.”

LOGISTEC Board Recommendation

LOGISTEC’s Board of Directors has evaluated the Arrangement Agreement with the Corporation’s management and legal and financial advisors, and following the receipt and review of the unanimous recommendation of the Special Committee, the Board of Directors has unanimously determined that the transaction is in the best interests of LOGISTEC and is fair to its shareholders, and unanimously recommends that LOGISTEC’s shareholders approve the transaction.

Each of TD Securities Inc., as exclusive financial advisor to the Corporation, and Blair Franklin Capital Partners Inc., as independent financial advisor to the Special Committee, has provided a fairness opinion to the Board of Directors and the Special Committee, respectively, to the effect that, as of the date thereof, and based upon and subject to the assumptions, limitations and qualifications stated therein, the consideration to be received by LOGISTEC shareholders under the transaction is fair, from a financial point of view, to such shareholders.

Transaction Details

The transaction will be implemented by way of a plan of arrangement under the Business Corporations Act (Québec) and is expected to close in the first quarter of 2024, subject to customary closing conditions, including the receipt of regulatory approvals and clearances in Canada and the United States, LOGISTEC shareholder approval and Court approval. The transaction is not subject to any financing condition.

Required LOGISTEC shareholder approval for the transaction will consist of at least 66⅔% of the votes cast on the transaction by holders of Class A Common Shares and Class B Subordinate Voting Shares voting together as a single class at a special meeting of LOGISTEC shareholders. Concurrently with the execution of the Arrangement Agreement, the Purchaser has entered into a voting support agreement with Sumanic Investments Inc., holding Class A Common Shares and Class B Subordinate Voting Shares representing approximately 77% of the voting rights attached to the issued and outstanding shares of the Corporation, and voting support agreements with each of the directors and executive officers who own shares of the Corporation, pursuant to which they have agreed to vote all shares held by them in favour of the transaction, subject to customary exceptions.

The Arrangement Agreement contains non-solicitation covenants on the part of the Corporation, subject to the customary “fiduciary out” provisions. A termination fee of $32 million would be payable by the Corporation to the Purchaser in certain circumstances, including in the context of a superior proposal supported by the Corporation. The Corporation would also be entitled to a reverse termination fee of $59 million if the transaction is not completed in certain circumstances.

Following completion of the transaction, the Corporation will become a privately held company and will apply to cease to be a reporting issuer under Canadian securities laws and the Class A Common Shares and Class B Subordinate Voting Shares will no longer be publicly traded on the Toronto Stock Exchange.

Additional information regarding the transaction will be included in an information circular that LOGISTEC will prepare, file and mail to LOGISTEC shareholders in advance of the special meeting to be held to consider and approve the transaction. Copies of the Arrangement Agreement and the information circular will be available under the Corporation’s profile on SEDAR+ on www.sedarplus.ca.

Advisors

TD Securities Inc. is acting as exclusive financial advisor to the Corporation and Blair Franklin Capital Partners Inc. is acting as independent financial advisor to the Special Committee. Rothschild & Co is acting as exclusive financial advisor to Blue Wolf. Stikeman Elliott LLP is acting as independent legal advisor to the Special Committee and Fasken Martineau DuMoulin LLP and K&L Gates LLP as legal advisors to the Corporation. McCarthy Tétrault LLP and Willkie Farr & Gallagher LLP are acting as legal advisors to Blue Wolf. Davies Ward Phillips & Vineberg LLP is acting as legal advisor to Sumanic Investments Inc.

About LOGISTEC Corporation

LOGISTEC Corporation is based in Montréal (QC) and provides specialized services to the marine community and industrial companies in the areas of bulk, break-bulk and container cargo handling in 60 ports and 90 terminals located in North America. LOGISTEC also offers marine transportation services geared primarily to the Arctic coastal trade as well as marine agency services to shipowners and operators serving the Canadian market. Furthermore, the Corporation operates in the environmental industry where it provides services to industrial, municipal, and other governmental customers for the renewal of underground water mains, dredging, dewatering, contaminated soils and materials management, site remediation, risk assessment, and manufacturing of fluid transportation products.

The Corporation has been profitable and has paid regular dividends since becoming public and payments have grown steadily over the years. A public company since 1969, LOGISTEC’s shares are listed on the Toronto Stock Exchange under the ticker symbols LGT.A and LGT.B. More information can be obtained on the Corporation’s website at www.logistec.com.

About Blue Wolf Capital Partners

Blue Wolf Capital Partners LLC is a private equity firm that focuses on value investments in middle market companies in the healthcare and industrial sectors. The firm’s integrated team of investment professionals and veteran operating executives work collaboratively to generate returns by driving transformational change using operational and strategic experience. Blue Wolf seeks to invest in businesses that have catalysts for value creation that involve organizational transformation, complex union or human capital issues, significant government presence,  or the opportunity to use ESG-informed strategies. For additional information, please visit www.bluewolfcapital.com.

About Stonepeak

Stonepeak is a leading alternative investment firm specializing in infrastructure and real assets with approximately $57.1 billion of assets under management. Through its investment in defensive, hard-asset businesses globally, Stonepeak aims to create value for its investors and portfolio companies, and to have a positive impact on the communities in which it operates. Stonepeak sponsors investment vehicles focused on private equity and credit. The firm provides capital, operational support, and committed partnership to sustainably grow investments in its target sectors, which include communications, energy and energy transition, transport and logistics, social infrastructure, and real estate. Stonepeak is headquartered in New York with offices in Hong Kong, Houston, London, Singapore, and Sydney. For more information, please visit www.stonepeak.com.

Early Warning Disclosure

As at the date hereof, Sumanic Investments Inc. (“Sumanic”) owns 5,802,578 Class A Common Shares and 6,600 Class B Subordinate Voting Shares, representing approximately 45% of the issued and outstanding shares of LOGISTEC and 77% of the outstanding votes of LOGISTEC, and currently files early warning reports pursuant to the requirements of Regulation 62-104 respecting Take-Over Bids and lssuer Bids and Regulation 62-103 respecting the Early Warning System and Related Take-Over Bid and lnsider Reporting Issues with respect to LOGISTEC. An amended early warning report, stating that Sumanic has entered into a support and voting agreement with the Purchaser pursuant to which it has agreed to vote, at the special meeting of the shareholders of LOGISTEC, in favour of the arrangement contemplated by the Arrangement Agreement will be filed with the applicable securities commissions and will be made available on SEDAR+ at www.sedarplus.ca. Further information, including a copy of the early warning report may be obtained by contacting Madeleine Paquin, director of Sumanic at 514-237-2949 and Nicole Paquin, director of Sumanic, at 514-212-2325.

Forward-Looking Statements

This press release contains forward-looking information, within the meaning of applicable securities legislation, including statements relating to the anticipated benefits of the transaction for the Corporation and its stakeholders, regulatory, shareholder and Court approvals and the anticipated timing of completion of the transaction. These forward-looking statements express, as of the date of this press release, the estimates, predictions, projections, expectations, or opinions of the Corporation about future events or results, including the ability of the parties to receive, in a timely manner and on satisfactory terms, the necessary regulatory, shareholder and Court approvals, the ability of the parties to satisfy, in a timely manner, the other conditions to the closing of the transaction and the completion of the transaction on expected terms, the impact of the transaction and the dedication of substantial resources from the Corporation to pursuing the transaction on the Corporation’s ability to maintain its current business relationships and its current and future operations, financial condition and prospects and statements relating to IQ’s potential participation in the transaction and any potential related undertakings in connection therewith. Although the Corporation believes that the expectations produced by these forward-looking statements are founded on valid and reasonable bases and assumptions, these forward-looking statements are inherently subject to important uncertainties and contingencies, many of which are beyond the Corporation’s control, such that the Corporation’s performance may differ significantly from the predicted performance expressed or presented in such forward-looking statements. The important risks and uncertainties that may cause the actual results and future events to differ significantly from the expectations currently expressed include the possibility that the transaction will not be completed on the terms and conditions, or on the timing, currently contemplated, and that it may not be completed at all, due to a failure to obtain or satisfy, in a timely manner or otherwise, required regulatory, shareholder and Court approvals and other conditions to the closing of the transaction or for other reasons; the failure to complete the transaction which could negatively impact the price of the shares or otherwise affect the business of the Corporation; the dedication of significant resources to pursuing the transaction and the restrictions imposed on the Corporation while the transaction is pending; the uncertainty surrounding the transaction that could adversely affect the Corporation’s retention of customers and business partners; the occurrence of a material adverse effect leading to the termination of the Arrangement Agreement, as well as the additional risks and uncertainties examined under business risks in the Corporation’s 2022 annual report. The transaction contemplated in this press release is not contingent on IQ’s participation in the transaction. The reader of this press release is thus cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to update or revise these forward-looking statements, except as required by law.

For further information:

Investors

Carl Delisle, CPA auditor
Chief Financial Officer and Treasurer
LOGISTEC Corporation
cdelisle@logistec.com
(514) 985-2390

Media

Mary-Chantal Savoy
Vice-President, Strategy and Communications
LOGISTEC Corporation
Phone: (514) 985-2337
msavoy@logistec.com

For Enquiries about Blue Wolf

Anna Fernandes
Ryan Public Affairs & Communications
anna@ryanap.com
(514) 973-6016

For Enquiries about Stonepeak

Kate Beers / Maya Brounstein
Communications
corporatecomms@stonepeak.com
+1 (212) 907-5100

Categories: News

Tags:

Pole Star Global Acquires StratumFive Group, Expanding Its Coverage in Fleet Monitoring & Voyage Optimisation for the Global Commercial Flee

Abry Partners logo

Combined offering expands Pole Star’s industry leading fleet coverage and complements its leadership in vessel sanctions and monitoring.

[London, October 16, 2023] – Pole Star Global, the pioneer and market leader in maritime intelligence technology, with the largest blue water fleet under management, is pleased to announce its successful acquisition of StratumFive Group, a prominent maritime tech company. StratumFive’s Podium5, an award winning voyage informatics platform, brings together fleet monitoring, regulatory compliance, performance analytics and voyage optimisation into one powerful platform.

The acquisition of StratumFive represents a natural progression for Pole Star Global, as both companies share a deep-rooted dedication to delivering innovative solutions that empower the maritime community. The combination expands Pole Star’s industry leading fleet coverage and complements its leadership in vessel compliance and tracking solutions, with PurpleTRAC and MDA, used by leading government agencies, global banks and vessel operators globally. The Podium5 platform leverages the previously acquired FleetWeather capability, with a proven track record of enhancing vessel performance and safety through advanced model-based route optimisation.

“We are excited to welcome StratumFive into the Pole Star family” said Bob Skea, CEO of Pole Star Global. “By joining forces, we are reaffirming our commitment to innovation for our customers. The Podium5 platform not only enhances our capabilities in vital voyage analytics, but also accelerates our efforts with vessel emissions transparency and planning, which is critical as we enable trusted partners throughout the maritime network. We are excited to be working with Stuart, Ross and team.”

Commenting on the acquisition, Stuart Nicholls, Founder of StratumFive Group, said, “We are excited to become part of the Pole Star family. This partnership will allow us to accelerate the development of innovative solutions that will further transform the maritime industry. Together, we will continue to provide our customers with the best-in-class services and support they expect.”

Stuart Nicholls and StratumFive CEO Ross Martin will join Pole Star in newly created leadership positions to ensure continuity for customers and partners.

Said Ross Martin, CEO, StratumFive Group, “Podium5 provides the solution that our industry desperately needs to realise digitalisation and other operational efficiencies around shipping. Our outreach to the sector throughout Podium’s development has shown that it is a gamechanger for decision-making. We are extremely excited to be working with Pole Star to drive digital prosperity across our industry.’’

About Pole Star

Pole Star Global is trusted by the world’s top regulatory entities and is the only company in the world that operates at the epicentre of the maritime ecosystem by connecting government agencies, financial markets & ship owners and operators. Stakeholders depend on Pole Star to assess responsible actors and bridge the gap between service providers, regulators, and funders. Our unrivalled predictive maritime Insights, data, and expertise enable our customers to act responsibly in the areas of trade finance, emissions control, life at sea, surveillance, sanctions avoidance, and operational and reputational risk management.

About StratumFive

StratumFive Group has been a trusted provider of leading software solutions to the commercial shipping community for more than a decade. Its global network includes the previously acquired FleetWeather operations centre in the USA and its 50-year history of service excellence.  At the beginning of 2022, the group launched Podium5, an advanced voyage informatics platform.  Podium5 empowers maritime operators to save time, save fuel, reduce emissions, and ensure regulatory compliance – all whilst ensuring the utmost safety of crew, vessel and cargo.

Categories: News

Tags:

GuidePoint Security Attracts New Round of Growth Capital

Audax Group

HERNDON, Va. — GuidePoint Security, a cybersecurity solutions leader enabling organizations to make smarter decisions and minimize risk, today announced the closing of a funding round led by Audax Private Equity, a leading alternative investment manager and capital partner to middle market companies. GuidePoint will leverage the investment to further accelerate growth across the United States and expand internationally. Terms of the new investment are not disclosed.

“As the complexity of the cybersecurity landscape becomes more pronounced — with ever evolving threats, thousands of products, and continued resource challenges — demand for our services and solutions has never been higher,” said Michael Volk, Chairman and CEO of GuidePoint Security. “We attribute this consistent and continued rapid growth to our steadfast commitment to partnering with our customers to solve their cybersecurity challenges. We’ve focused on hiring the best and brightest cybersecurity minds across the United States and investing in innovative service offerings to address new and emerging risks. Now with Audax Private Equity, we are set up to help even more customers across the U.S. and expand overseas.”

Founded in 2011, GuidePoint Security has become the trusted cybersecurity advisor to more than 3,800 organizations across the U.S., including one-third of the Fortune 50 and 40% of the Fortune 500, along with more than half of the U.S. government cabinet-level agencies. The company’s unique business model provides local engagement and delivery teams, national scale and purchasing power for industry-leading cybersecurity solutions, breadth and depth of cybersecurity expertise across all disciplines, and engagements that are tailored to each customer’s specific environment and needs.

“GuidePoint has distinguished itself as one of the premier providers of cybersecurity solutions, where local coverage, sophisticated technical skillsets, and industry expertise are crucial to address, mitigate and stay ahead of cyber risks,” noted Iveshu Bhatia, a Managing Director at Audax Private Equity. “Our investment experience in this area should prove beneficial as we work closely with the GuidePoint team to drive growth.”

“GuidePoint Security’s value proposition revolves around the team’s sophisticated technical skillset coupled with deep industry expertise,” added Tim Mack, Partner of Audax Private Equity. “We see a tremendous opportunity to invest in the company’s continued expansion and build upon its track record of growth over the last 12 years.”

Guggenheim Securities, LLC served as the exclusive financial advisor, while DLA Piper provided legal counsel. Kirkland & Ellis served in the same capacity to Audax Private Equity. ABS Capital Partners, a prior investor in GuidePoint Security, participated in the transaction.

ABOUT

About GuidePoint Security:

GuidePoint Security provides trusted cybersecurity expertise, solutions and services that help organizations make better decisions that minimize risk. Our experts act as your trusted advisor to understand your business and challenges, helping you through an evaluation of your cybersecurity posture and ecosystem to expose risks, optimize resources and implement best-fit solutions. GuidePoint’s unmatched expertise has enabled a third of Fortune 500 companies and more than half of the U.S. government cabinet-level agencies to improve their security posture and reduce risk. Learn more at www.guidepointsecurity.com.

About Audax Private Equity:

Based in Boston and San Francisco, Audax Private Equity is a leading middle market investment firm with approximately $18 billion of assets under management, over 210 employees, and 100-plus investment professionals. Since its founding in 1999, the firm has invested in more than 165 platforms and 1,200 add-on acquisitions. Through our disciplined Buy & Build approach, across six core industry verticals, Audax helps portfolio companies execute organic and inorganic growth initiatives that fuel revenue expansion, optimize operations, and significantly increase equity value. For more information, visit audaxprivateequity.com or follow Audax Private Equity on LinkedIn.

“GuidePoint Security’s value proposition revolves around the team’s sophisticated technical skillset coupled with deep industry expertise. We see a tremendous opportunity to invest in the company’s continued expansion and build upon its track record of growth over the last 12 years.”
Tim Mack
Partner, Audax Private Equity

Categories: News

Tags:

Invitation to the presentation of Ratos Interim report January-September 2023

Ratos

The Interim report January-September 2023 will be released on Monday 23 October at 07.00 CEST.

At 09.00 CEST will Jonas Wiström, President and CEO, and Jonas Ågrup, CFO, present the report.

The presentation can be followed on Youtube via the following link; https://youtube.com/live/zmOVIGWY3fg?feature=share
The live presentation will be recorded and is available afterwards via the same link.

Participants who wish to ask questions live are asked to pre-register, please send an e-mail to helena.jansson@ratos.com in advance for a personal invitation.

The presentation and report will be available on www.ratos.com after publication.

Representatives of the media are welcome to contact Josefine Uppling, VP Communication, for interview requests.

For further information
Josefine Uppling, Vice President Communication
+46 76 114 54 21
josefine.uppling@ratos.com

About Ratos
Ratos is a business group consisting of 16 companies divided into three business areas: Construction & Services, Consumer and Industry. The companies have approximately SEK 33 billion in net sales (LTM). Our business concept is to own and develop companies that are or can become market leaders. We have a distinct corporate culture and strategy – everything we do is based on our core values: Simplicity, Speed in execution and It’s All About People. We enable independent companies to excel by being part of something larger. People, leadership, culture and values are key focus areas.

Categories: News

Conclusion acquires Portuguese Neotalent

NPM Capital

Conclusion acquires Portuguese Neotalent

Business transformation and IT service provider Conclusion has reached an agreement with the investment company Novabase to acquire the leading Portuguese organization Neotalent, a specialist in recruiting and deploying IT talent. The organization currently employs over 800 experienced specialists in high-demand technology areas such as software development, data analysis, cloud services and engineering. Neotalent has been steadily growing in recent years and provides nearshore and onshore solutions to renowned companies in Portugal and Spain. As part of Conclusion, Neotalent is ideally positioned to strengthen Dutch customer teams, enabling them to meet the high demand for qualified multidisciplinary teams. The acquisition of Neotalent will take place in the coming months, subject to the verification of certain customary conditions typically associated with similar transactions, including the approval of the Portuguese competition authority.

 

Engbert Verkoren, CEO of Conclusion, says, “Welcoming Neotalent is a significant step for Conclusion. With this addition to our ecosystem, we attain the necessary capacity to provide effective nearshore services as an integral part of our overall service, addressing the business and IT challenges of our clients. Compared to Portuguese competitors, Neotalent has proven to be very successful in finding the right people in the tight Portuguese labor market. Furthermore, Neotalent’s management is capable of forming long-term relationships with both employees and customers by investing in talent development and promoting a culture centered around responsibility and collaboration. We support the further development of Neotalent into a full-service IT provider, both in Portugal and Spain and beyond.”

 

Álvaro José Ferreira, a member of Novabase’s Board of Directors, states, “This agreement accelerates Novabase’s growth strategy by dedicating all our resources and energy to the international expansion of the NextGen business, particularly in the area of cognitive and analytics. At the same time, we believe that Neotalent, through integration into Conclusion’s ecosystem, can continue to operate autonomously while maintaining its identity. By combining this with the highly qualified management team and the group of skilled professionals, Neotalent can propel its further development as a best-in-class nearshore player.”

 

Célia Vieira, director of Neotalent, regarding the acquisition, says, “This is an important moment for Neotalent. By being part of an international player like Conclusion, we can enter new markets and take on new business challenges, leveraging the extensive and high-quality services and solutions portfolio of the group. We see a great opportunity to combine our growth ambition with Conclusion’s ambition to establish a strong nearshore capacity. This also aligns with our mission to become a European reference player in our sector. We are pleased to join the Conclusion’s ecosystem. This offers growth opportunities for all of us and enhances the business appeal of our company.”

 

About Neotalent

Neotalent has 25 years of experience in delivering and managing IT talent services to meet the business needs of companies in various sectors and markets. Currently, more than 800 specialized professionals work at Neotalent. With offices in Portugal and Spain, Neotalent is a leading IT & Engineering service partner that combines the best technical expertise with an agile way of thinking to strengthen businesses and make organizations successful.

Categories: News

Tags: